NEW YORK, May 7 -- Exact Sciences of Maynard, Mass., and Genzyme Genetics, a subsidiary of Genzyme General, today announced the signing of a cross-license and collaboration agreement covering 15 technology patents.
Registering provides access to this and other free content.
Already have an account?Login Now.
The Wall Street Journal speaks with patients affected by questionable test results from Theranos.
Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.
Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.
In Science this week: convergent evolution in bird hemoglobin, and more.